ADP101 Simultaneous Multi- food Oral Immunotherapy (mOIT) Demonstrates Clinically Meaningful Safety and Efficacy with Dose- Dependent Response in Pediatric Patients in the Phase 1/2 Harmony Trial

ADP101 - Alladapt Immunotherap

Edwin Kim; Amy Archer; Mei-Lun Wang; Amy Sullivan; Nusrat Rabbee; Ashley Dombkowski; Dana Mcclintock

May 13, 2023